Head-to-head GLP-1 comparisons
Side-by-side breakdowns of the providers and drugs that matter.
Side-by-side: NexLife's $145/mo flat-rate compounded GLP-1 vs Hims' brand-routing model after the Novo partnership. Pricing, oversight, labs, pharmacy partners.
Ro's $249 brand Wegovy subscription vs NexLife's $145 compounded semaglutide. Twelve-month lockup, drug type, lab inclusion, coaching — broken down.
Two flat-rate compounded providers, very different prices. NexLife is $145/mo. Henry Meds is $297. Here is exactly what is and isn't included on each side.
Strut Health is a boutique compounded clinic at $245/mo. NexLife is $145. Both are MD-supervised, all 50 states. Here is what tips the rubric.
Two transparent compounded providers. NexLife at $145/mo includes labs, coaching, and 503B-pharmacy access. TrimRx at $179/mo. Breakdown by rubric.
Two of the biggest DTC telehealth brands. Pricing, drug routing, and what changed after the Novo partnership.
Ozempic and Wegovy are both semaglutide, made by Novo Nordisk. Here's the FDA-labeled difference, dosing, and what it means for cost and coverage.
Semaglutide (Ozempic) vs tirzepatide (Mounjaro) for weight loss and Type 2 diabetes. Mechanism, head-to-head trial data, dosing, and cost.
Ozempic (semaglutide) vs Zepbound (tirzepatide). Trial data, dosing, side effects, and cost for weight loss.
Wegovy (semaglutide) vs Zepbound (tirzepatide) for weight management. Efficacy, cost, coverage, side effects.
Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 agonist. Here's what that means for efficacy, side effects, and cost.
What 'compounded' actually means, when it's legal, how 503A and 503B pharmacies work, and how to evaluate compounded GLP-1 safely.
Rybelsus, Foundayo, and compounded oral GLP-1s vs injectable semaglutide and tirzepatide. Bioavailability, dosing, and weight-loss outcomes.
Foundayo (orforglipron) is Eli Lilly's first-oral GLP-1 for obesity, approved 2026. How it stacks up against Wegovy on efficacy, dosing, cost.
Willow vs Ro for GLP-1. Pricing, drug type, and program structure for women considering both.
Two budget compounded options side by side.
Two budget compounded providers with thin verification.
Both are semaglutide from Novo Nordisk — one is injectable, one is a daily oral pill.
Older daily liraglutide vs once-weekly semaglutide for chronic weight management.
Sermorelin is a GHRH analog. Semaglutide is a GLP-1 agonist. They do different things.